ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 26 2024
0mins
Source: Newsfilter
Special Dividend Announcement: ARCA biopharma has declared a special cash dividend of $1.613 per share, payable on August 28, 2024, to stockholders of record as of August 26, 2024, in connection with its merger with Oruka Therapeutics.
Ex-Dividend Date and Trading Implications: The ex-dividend date is set for August 29, 2024, and trades during the due bill period from August 25 to August 28 will affect eligibility for the dividend, requiring buyers to hold shares through the payment date to receive it.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
